Cannabinoids are compounds found in the cannabis sativa plant. Cannabinoids, such as
delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have potential therapeutic …

The endocannabinoid system receptors, cannabinoid receptors type-1 (CBR-1) and− 2
(CBR-2), are implicated in several behavioral and cognitive processes. Many studies have …

Ischemic stroke, a cerebrovascular disease worldwide, triggers a cascade of
pathophysiological events, including blood‐brain barrier (BBB) breakdown. Brain …

Brain angiogenesis, the formation of new blood vessels from existing brain vasculature, has
been previously associated with neural plasticity and addictive behaviors related to …

Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic
origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose …

Ischemic stroke is a disease in which brain tissue is damaged by a sudden rupture or
blockage of a blood vessel in the brain that prevents blood from flowing to the brain …

Cannabinoids are a class of drugs derived from the Cannabis plant that are widely used for
the treatment of various medical conditions and recreational use. Common examples …

Introduction: Synthetic cannabinoids (SCs) are new psychoactive compound that mimic the
actions of tetrahydrocannabinol, the main psychoactive ingredient in cannabis …

Aim: This study aims to explore the impact of the synthetic cannabinoid methyl 2-(1-(4-
fluorobenzyl)-1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (MDMB-FUBINACA) on …

Angiogenesis is the process by which blood vessels are generated from preexisting ones.
Synthetic cannabinoids represent new psychoactive substances that bind to the …